home / stock / snoa / snoa news

SNOA News and Press, Sonoma Pharmaceuticals Inc.

Stock Information
Company Name: Sonoma Pharmaceuticals Inc.
Stock Symbol: SNOA
Market: NASDAQ
Website: sonomapharma.com
Menu
SNOA SNOA Quote SNOA Short SNOA News SNOA Articles SNOA Message Board
Get SNOA Alerts

News, Short Squeeze, Breakout and More Instantly...
SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $4.3M

2026-02-10 16:44:09 ET More on Sonoma Pharmaceuticals Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals Historical earnings data for Sonoma Pharmaceuticals Financial information for Sonoma Pharmaceuticals Read the full article on Seeking Alpha ...
SNOA - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior year Net loss and net loss per share decreased from prior year for both the three months and nine months ended December 31, 2025 EBITDAS loss decreased...

SNOA - Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye...

SNOA - National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, ey...
SNOA - Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye...

SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.32 misses by $0.01, revenue of $5.6M beats by $1.34M

2025-11-04 12:16:34 ET More on Sonoma Pharmaceuticals Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals Historical earnings data for Sonoma Pharmaceuticals Financial infor...

SNOA - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods last year U.S. revenue increased 115% for the quarter and 86% for the six months ended September 30, 2025 compared to same periods last year Net loss per share decreas...
SNOA - Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

BOULDER, CO, AL / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in developing and producing stabilized hypochlorous acid (HOCl) products based on its patented Microcyn ® technology, today announced the launch of a new HOCl wou...

SNOA - Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law

2025-10-07 08:49:08 ET More on Sonoma Pharmaceuticals Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals Historical earnings data for Sonoma Pharmaceuticals Financial information for Sonoma Pharmaceuticals Read the full article on Seeking Alpha ...

SNOA - Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology-based stabilized hypochlorous acid (HOCl) products, today announced that it has successfully registered i...
Next 10